Figure 3.

The effect of Tat-protein (A), Cr (B), GPA (C, E) or Tat-BCK (D) treatment on BCK (A-D) or CRT (E) immunoreactivity in the rat hippocampus. As compared to controls, Cr or Tat-BCK treatment increased BCK immunoreactivity in the rat hippocampus. GPA treatment reduced BCK and CRT immunoreactivity in ther at hippocampus. Rectangles in panels 1 indicate the regions of panels 2 and 3. Bar = 200 (panel 1) and 25 (panels 2-4) μm.

Kim et al. BMC Neuroscience 2010 11:141   doi:10.1186/1471-2202-11-141
Download authors' original image